MKI67 and neoplasm: Pro-inflammatory cells, such as tumor-infiltrating lymphocytes (TILs), tumor-associated macrophage-like cells (TAMs), and proliferation markers, such as Ki67, have been used as biomarkers for studying response and predicting pCR in the NAC setting [21,22,23].